FBH1 influences DNA replication fork stability and homologous recombination through ubiquitylation of RAD51

Abstract

Unscheduled homologous recombination (HR) can lead to genomic instability, which greatly increases the threat of neoplastic transformation in humans. The F-box DNA helicase 1 (FBH1) is a 3'-5' DNA helicase with a putative function as a negative regulator of HR. It is the only known DNA helicase to contain an F-box, suggesting that one of its functions is to act as a ubiquitin ligase as part of an SCF (SKP1, CUL1 and F-box) complex. Here we report that the central player in HR, RAD51, is ubiquitylated by the SCF^FBH1 complex. Expression of an ubiquitylation-resistant form of RAD51 in human cells leads to hyperrecombination, as well as several phenotypes indicative of an altered response to DNA replication stress. These effects are likely to be mediated by the enhanced nuclear matrix association of the ubiquitylation-resistant RAD51. These data are consistent with FBH1 acting as a negative regulator of RAD51 function in human cells.

ARTICLE

Received 26 Aug 2014 | Accepted 19 Nov 2014 | Published 14 Jan 2015

Unscheduled homologous recombination (HR) can lead to genomic instability, which greatly increases the threat of neoplastic transformation in humans. The F-box DNA helicase 1 (FBH1) is a 3050 DNA helicase with a putative function as a negative regulator of HR. It is the only known DNA helicase to contain an F-box, suggesting that one of its functions is to act as a ubiquitin ligase as part of an SCF (SKP1, CUL1 and F-box) complex. Here we report that the central player in HR, RAD51, is ubiquitylated by the SCFFBH1 complex. Expression of an ubiquitylation-resistant form of RAD51 in human cells leads to hyperrecombination, as well as several phenotypes indicative of an altered response to DNA replication stress. These effects are likely to be mediated by the enhanced nuclear matrix association of the ubiquitylation-resistant RAD51. These data are consistent with FBH1 acting as a negative regulator of RAD51 function in human cells.

DOI: 10.1038/ncomms6931

FBH1 inuences DNA replication fork stability and homologous recombination through ubiquitylation of RAD51

Wai Kit Chu1,2,*, Miranda J. Payne1,*, Petra Beli3, Katsuhiro Hanada1, Chunaram Choudhary3 & Ian D. Hickson1,2

1 Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK. 2 Center for Healthy Aging, Department of Cellular and Molecular Medicine, Panum Institute, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N, Denmark. 3 Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, 2200 Copenhagen N, Denmark. * These authors contributed equally to this work. Correspondence and requests for materials should be addressed to I.D.H. (email: mailto:[email protected]

Web End [email protected] ).

NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 1

& 2015 Macmillan Publishers Limited. All rights reserved.

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931

Faithful DNA replication is essential for cell proliferation. Nevertheless, a number of circumstances can arise in cells that lead to the stalling or collapse of DNA replication forks.

On short-term replication blockage, such as following exposure of cells to the ribonucleotide reductase inhibitor, hydroxyurea (HU), the replication machinery is stalled, but remains bound to the DNA1. If the duration of replication stalling is prolonged, the replisome components can detach from the stalled fork, and the exposed fork can be processed into a double-strand break (DSB). This fork breakage process is most probably mediated by the DNA structure-specic endonuclease MUS81-EME1 (ref. 2). Under these circumstances, the fork is deemed to have collapsed. Stalled and collapsed forks both require the protective function of the RAD51 recombinase, but different roles of RAD51 are apparently required in each case. In the case of a stalled fork, RAD51 serves to stabilize the fork, in a process that does not appear to require the canonical homologous recombination (HR) machinery. In this pathway, RAD51 has been proposed to coat the single-stranded DNA (ssDNA) region adjacent to the stalled fork, potentially facilitating the formation of a Holliday junction via so-called fork regression (reversal), which involves the annealing of the two nascent DNA strands3. Indeed, the RAD51 homologue in Escherichia coli, RecA, has been demonstrated to promote this process in vitro4. In addition, RAD51 has been reported to protect the nascent DNA from MRE11-mediated degradation at stalled replication forks5,6. In contrast to this HR-independent function of RAD51, the canonical HR pathway is known to operate at collapsed forks, where a DSB is generated. One of the key steps in repair of the single-ended DSB formed at a collapsed fork is the formation of a RAD51 protein lament on the ssDNA generated by DSB end resection. This nucleoprotein lament is required for the search for a homologous DNA sequence and for repair of the break7. RAD51 is also involved in the reassembly of key DNA replication proteins, including the so-called CMG complex comprising CDC45-MCM-GINS, after replication forks have collapsed8. Despite this protective role of RAD51 and HR factors more generally at stalled/collapsed replication forks, it is clear that uncontrolled HR can lead to genome rearrangements and loss of heterozygosity, which are potent drivers of tumorigenesis9. As RAD51 is a key player in replication-associated HR, controlling the binding of RAD51 to its potential DNA substrates or to chromatin more generally would be an effective means to regulate the balance between the benecial and detrimental roles of HR in an effort to preserve genome stability.

Several DNA helicases have been identied that can control the stability of a RAD51 nucleoprotein lament1013. Many of these belong to the UvrD family of proteins, such as Srs2 in yeast and PARI in mammals1214. Mammalian cells express another UvrD family member, FBH1 (F-box DNA helicase 1), which has been reported previously to suppress HR15. FBH1 is conserved in human, mouse and Schizosaccharomyces pombe cells, but is not found in Saccharomyces cerevisiae16. In addition to the helicase domain, there is an amino-terminal F-box domain present in FBH1. F-box proteins form part of the so-called SCF complexes (SKP1-CUL1-F-box protein), which generally act as E3 ubiquitin ligases17. Ubiquitylation is a posttranslational modication that leads to the covalent attachment of the ubiquitin peptide to particular lysine residues in the target protein. This modication may regulate the substrates function or target the substrate for proteasomal degradation17. Previous data derived from studies inS. pombe have suggested that both the F-box domain and the helicase domain of Fbh1 are required for the repair of DNA damage in that organism, although the helicase function seems more critical18,19. Moreover, genetic analysis suggested that yeast Fbh1 acts downstream of Rad51 in the HR pathway18,20.

Consistent with this, the level of Rad51 nuclear foci is greatly increased in Fbh1-decient yeast, a phenotype that is also characteristic of FBH1-depleted human cells15,21,22. Recently, we found that the helicase function of FBH1 co-operates with the MUS81-EME1 nuclease in generating DSBs following replication stress induced by HU23. FBH1 is often mutated in melanoma cells, which suggests that the DSBs generated in this context by the action of FBH1 might serve to trigger apoptosis, to prevent oncogenic transformation24,25. Interestingly, human and mouse cells expressing a helicase-dead version of FBH1 are resistant to the cytotoxic effects of replication stress induced by HU23. In addition, FBH1 forms HU-induced nuclear foci that co-localize with the ssDNA-binding protein, RPA15. These observations strongly implicate the helicase function of FBH1 in coping with some aspect of DNA replication stress. Consistent with this, recent data indicate that human FBH1 can displace RAD51 laments from ssDNA22. However, the role of the F-box domain of FBH1 remains undened.

Although UvrD family helicases are implicated in the regulation of RAD51 function in a diverse range of cell types, it is not clear whether the F-box also plays a role in regulating RAD51 or HR more generally in mammalian cells. Indeed, it has been reported that an F-box-mutated variant of S. pombe Fbh1 is largely functional, which implies the F-box may only play a minor role in HR and in the cellular response to replication problems in that organism18. In human cells, the substrate of the FBH1 ubiquitylation and the role of the F-box in pathways for coping with replication stress are currently unknown. Here we have addressed these issues. We demonstrate that RAD51 can be ubiquitylated by the SCFFBH1 complex in vitro. In cells expressing an ubiquitylation-resistant form of RAD51, the RAD51 protein shows enhanced chromatin association during replication stress. In these cells, the frequency of replication fork stalling is reduced, while recovery of replication following replication stress is enhanced. These cells also show increased resistance to replication inhibitors, and hyperrecombination, consistent with a role for FBH1 in regulating RAD51 function in human cells.

ResultsRAD51 is ubiquitylated by the SCFFBH1 complex in vitro. The FBH1 protein is implicated in the control of RAD51 function, most probably in the context of stalled or damaged DNA replication forks. Although the helicase function of FBH1 is thought to regulate the stable association of RAD51 with DNA, the role of the F-box domain in FBH1 has not been dened. To investigate the function of the F-box, we puried recombinant human FBH1, together with the other SCF complex components, as well as human RAD51 protein (Supplementary Fig. 1a,b). The puried SCFFBH1 complex was then tested for its ability to ubiquitylate the puried RAD51 protein in vitro. In the presence of SCFFBH1 and ubiquitin, a new species of the RAD51 protein (which normally migrates at 37 kDa on SDSpolyacrylamide gel electrophoresis (PAGE)) was observed with a migration equivalent to 50 kDa (Fig. 1a). This would be consistent with the addition of a single ubiquitin moiety to the RAD51 protein. To conrm that this protein modication was via ubiquitylation, we repeated the reactions using haemagglutinin (HA) epitope-tagged ubiquitin instead of untagged ubiquitin. In this case, the modied RAD51 showed a further reduction in mobility on SDSPAGE due to the presence of the HA tag (Fig. 1a). Hence, we conclude that SCFFBH1 can ubiquitylate RAD51 in vitro. This modication required, as expected, an E1 enzyme and an E2 enzyme (Supplementary Fig. 1c), but occurred independently of the presence or absence of ssDNA (Fig. 1b). A negative control reaction is shown in Fig. 1d described below, to demonstrate a

2 NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

& 2015 Macmillan Publishers Limited. All rights reserved.

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931 ARTICLE

Ub Ub-HA

HA-Ub-RAD51 Ub-RAD51

RAD51

50 kDa

ssDNA +

37 kDa

50 kDa Ub-RAD51RAD51

37 kDa

57

64

Human

58

PK K E L I N I

K

K

GI S E

Ub-HA

WT RAD51 K58/64R RAD51 + +

Fission yeast

PK RQL L L I

GI S E

50 kDa

Ub-RAD51

RAD51

37 kDa

Figure 1 | RAD51 is ubiquitylated in vitro by FBH1. (a) Western blotting of products from ubiquitylation of RAD51 by SCFFBH1 probed with an anti-RAD51 antibody. The positions of the unmodied RAD51, the ubiquitylated RAD51 (ub-RAD51) and the HA-Ub RAD51 are shown on the right. (b) The ubiquitylation of RAD51 by SCFFBH1 has no requirement for ssDNA. (c) Protein sequence alignment of a region of the human and S. pombe RAD51 proteins. The conserved lysines/arginines are bracketed and their positions are numbered above. (d) WT RAD51 or RAD51 containing mutations of lysines to arginines on position 58 and 64 (K58/64R) were subjected to in vitro ubiquitylation by SCFFBH1. The and symbols denote the presence or absence of

the indicated protein, respectively. A western blot is shown of the products of the assay probed with an anti-RAD51 antibody.

requirement for ubiquitin itself. The preferred E2 appeared to be UbcH5a, which could not be replaced by Cdc34 or UbcH6 (Supplementary Fig. 1c,d). The reaction was also not stimulated by the presence of Nedd8 (Supplementary Fig. 1c). To assess whether there was any specicity to the reaction, we replaced RAD51 with RPA, FANCD2 or BLM protein. In none of these cases could we detect ubiquitylation by the SCFFBH1 complex (Supplementary Fig. 1e).

Identication of the sites of ubiquitylation on RAD51. A previous proteome-wide mass spectrometry study identied K58 and K64 on RAD51 as being ubiquitylated in human cells26. To identify whether these lysine residues could be targeted by SCFFBH1, we subjected the in vitro ubiquitylated RAD51 to mass spectrometry following trypsin digestion. This analysis provided 79% sequence coverage of RAD51. Five modied residues were identied within the population of RAD51 protein molecules, of which the most prominent were K58 and K64 (Supplementary Table 1). K58 and K64 are in the N-terminal domain of RAD51, which lies outside of the core RecA-like ATPase domain. Nevertheless, the region of RAD51 around K58/64 is conserved (Fig. 1c), despite the lack of overall conservation of the N-terminal domains of eukaryotic RAD51 proteins. To investigate the importance of the K58/64 residues in the modication of RAD51 by SCFFBH1, we puried a version of RAD51 containing arginine substitutions of K58 and K64. This protein, designated K58/64R RAD51, possessed a similar ability to interact physically with GST-FBH1 as did the WT RAD51 (Supplementary Fig. 1f). However, K58/64R RAD51 was ubiquitylated much less efciently by FBH1 in vitro than was wild-type (WT) RAD51 (Fig. 1d), conrming that the primary sites of modication by FBH1 on RAD51 are K58 and K64.

Role of RAD51 ubiquitylation in human cells. Next, we investigate the role of K58/64 modication of RAD51 in human cells. To do this, we compared the phenotype of U2OS cells expressing either WT RAD51 or K58/64R RAD51. We reasoned that a ubiquitylation-resistant form of RAD51 might potentially escape the control imposed by FBH1, and therefore be dominantly acting

even in cells expressing endogenous RAD51. We focused on the cellular response to replication stress, because our previous studies indicated that FBH1-decient mouse embryonic stem (ES) cells are abnormally resistant to HU-induced replication fork perturbation23. This resistance is manifested both as an increase in clonogenic survival after HU treatment and a decrease in DSB induction compared with WT cells. To analyse the effects of K58/64 ubiquitylation, we generated stable transfectants of U2OS cells expressing either WT or K58/64R RAD51. The level of transfected RAD51 was equal in both cases, and was in excess over that of the endogenous RAD51 by approximately twofold (Fig. 2a). Despite lacking any additional tag (because tags are known to adversely affect RAD51 function), the transfected RAD51 had a slightly slower mobility on SDSPAGE compared with the endogenous protein. This phenomenon has been observed in a previous study27. Conrmation that the protein species recognized by this antibody were all RAD51 came from analysis and cells exposed to a small interfering RNA (siRNA) targeted to the coding region of RAD51. After transfection of this siRNA, the level of the endogenous and transfected RAD51 was diminished greatly (Fig. 2a).

Next, we investigated the phenotypic affects of the transfected K58/64R RAD51. Consistent with previous data indicating that FBH1 gene mutation confers resistance to HU, we found that the cells expressing K58/64R RAD51 were signicantly more HU resistant than the isogenic control cells expressing WT-transfected RAD51 (Fig. 2b; Po0.05 using an unpaired t-test). In cells expressing K58/64R RAD51, the HU resistance was also signicant when the endogenous RAD51 protein was depleted using an siRNA targeting the 30-untranslated region (30-UTR) of

RAD51, a region of the RAD51 gene that is absent from the transfected RAD51 complementary DNAs (Supplementary Fig. 2a,b). These data argue that the endogenous RAD51 does not interfere with the dominant phenotypic effects seen when expressing ubiquitylation-resistant RAD51. Moreover, pulsed-eld gel electrophoresis analysis indicated that the K58/64R RAD51-expressing cells accumulated signicantly fewer DNA DSBs than did the WT RAD51-expressing cells following a 24-h exposure to HU (Fig. 2c; Po0.05 using an unpaired t-test). In cells expressing K58/64R RAD51, there was also a diminution in

NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 3

& 2015 Macmillan Publishers Limited. All rights reserved.

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931

siControl siRAD51

Untreated 2 mM HU 24 h

WT RAD51

K58/64R RAD51

WT RAD51

K58/64R RAD51

U2OS

WT RAD51

K58/64R RAD51

WT RAD51

K58/64R RAD51

Intact DNA

Broken DNA

U2OS

50kDa

37kDa

Tubulin

RAD51

0.4

Transfected RAD51 Endogenous RAD51

*

0.35

0.3

0.25

Broken

DNA / total DNA

0.2

0.15

0.1

0.05

100

80

% Survival

20

WT RAD51 K58/64R RAD51

Normalized

% of GFP cells

40

0

1.2 1

0.80.60.40.2 0

60

0 0 2 4 6

HU (mM)

WT RAD51

K58/64R RAD51

Figure 2 | Expression of K58/64R RAD51 inuences the cellular response to HU. (a) Western blotting of cells transfected with empty vector or a construct expressing either WT RAD51 or K58/64R RAD51, as indicated above the lanes. The set of three samples on the right were derived from cells treated with an siRNA targeted against the coding region of RAD51, to demonstrate the specicity of the antibody. The positions of the transfected and endogenous RAD51 species are indicated on the left. Tubulin was used as a loading control. The asterisk marks degradation products of RAD51, which were reported previously48. (b) Clonogenic survival curves following exposure of WT RAD51- and K58/64R RAD51-expressing cells to HU, as indicated in the key. Points represent the mean of three independent determinations. (c) Induction of DSBs by treating cells with 2 mM HU for 24 h. The upper panel shows a representative pulsed eld gel with triplicate samples for each, while the lower panel shows data for the average of three independent experiments. Bands were quantied by using ImageJ software. (d) Hyperrecombination in K58/64R RAD51-expressing cells as determined by using the DR-GFP assay. The percentage of cells expressing GFP was normalized to a control (a plasmid expressing RFP under the control of the same promoter). The means for two independent experiments are shown. Error bars represent s.d.

the level of DNA DSBs following HU treatment when the endogenous RAD51 was depleted by an siRNA targeting the 30-

UTR of RAD51 (Supplementary Fig. 2c). This difference in DSB levels required that the cells be subjected to prolonged HU treatment, and was much less evident after only a 12-h exposure to HU (Supplementary Fig. 2d). Interestingly, we found that the resistance to replication stress in K58/64R RAD51-expressing cells was not limited to HU, but was also seen with aphidicolin, which acts via a different mechanism from HU (direct polymerase inhibition, not dNTP depletion) (Supplementary Fig. 2e). However, the K58/64R RAD51-expressing cells were not hyperresistant to ionizing radiation (Supplementary Fig. 2f), suggesting a role for RAD51 ubiquitylation only during the cellular response to DNA replication stress.

Loss of FBH1 helicase function in mouse ES cells leads to spontaneous hyperrecombination, presumably because RAD51 escapes the normal control imposed by FBH1 (ref. 22). Using the widely used and previously validated direct repeat-green uorescent protein (DR-GFP) assay28, we found that the U2OS cells expressing K58/64R RAD51 also showed an approximately threefold increase in the level of recombination compared with control cells expressing WT RAD51 only (Fig. 2d; Po0.05 using an unpaired t-test). In cells expressing K58/64R RAD51, the level of recombination was also signicantly higher when the endogenous RAD51 was depleted by an siRNA targeting the 30-

UTR of RAD51 (approximately fourfold; Supplementary Fig. 2g,h).

Next, we investigated whether cells expressing either WT or K58/64R RAD51 responded differently following release from prolonged HU-induced arrest. To do this, the DNA bre technique was employed to quantify replication dynamics. Active

replicons were initially labelled by incorporation of CldU and then replication was arrested by exposure of cells to HU. Following removal of the HU, the ability of the cells to recover productive DNA replication was monitored by incorporation of IdU. Three categories of replication were quantied, as depicted in Fig. 3a: (i) irreversibly stalled forks (CldU tracts only; marked in red); (ii) forks that were competent to restart after HU exposure (adjacent red and green (IdU) tracts); (iii) new origin ring (IdU/green tracts only). In the absence of HU, there was no statistically signicant difference between any of these replication parameters in cells expressing WT RAD51 or K58/64R RAD51 protein (Fig. 3b). In contrast, following a 24-h exposure to HU, there was a signicant change in the proportion of forks that remained stalled or were able to restart. For the K58/64R RAD51-expressing cells, a smaller proportion of replication forks were irreversibly stalled and a correspondingly greater proportion of forks successfully re-initiated DNA synthesis compared with cells expressing WT RAD51 (Fig. 3b). Although new origin ring also appeared suppressed in the K58/64R RAD51 cells compared with the control cells, this difference did not reach statistical signicance. Equivalent results were also observed in K58/64 RAD51-expressing cells in which the endogenous RAD51 was depleted using an siRNA targeting the 30-UTR of RAD51 (Supplementary Fig. 3).

RAD51 ubiquitylation controls subcellular localization. It has been reported that both mouse ES cells lacking FBH1 helicase function and FBH1-depleted human cells show increased levels of RAD51 nuclear foci15. We analysed, therefore, whether

4 NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

& 2015 Macmillan Publishers Limited. All rights reserved.

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931 ARTICLE

Stalled fork

Fork restart

New origin firing

Untreated cells

100

WT RAD51 K58/64R RAD51

% Of replication forks

75

50

25

0

Stalled forks Fork restart New origin firing

2 mM HU 24 h

100

P < 0.01 P < 0.01

WT RAD51 K58/64R RAD51

% Of replication forks

75

50

25

0

Stalled forks Fork restart New origin firing

Figure 3 | Ubiquitylation on RAD51 inuences replication fork restart. (a) Representative pictures of a stalled fork, fork restart and new origin ring from cells exposed to 2 mM HU for 24 h. DNA synthesis occurring before or after HU treatment was stained as red and green tracts, respectively. Scale bar, 1 mm (white). (b) Quantication of the percentage of replicons with stalled forks, re-started forks or newly red origins for cells expressing WT RAD51 (black bars) or K58/64R RAD51 (hatched bars). The upper panel shows untreated cells and the lower panel shows cells exposed to HU for 24 h. The means are shown for two independent experiments. Where signicant (Po0.01), P-values are indicated. At least 180 forks for each cell line were quantied and the differences in the distributions of stalled forks and fork restart after HU treatment were evaluated statistically using an unpaired t-test. Error bars represent s.d.

ubiquitylation of RAD51 was important for regulating the subcellular localization of RAD51. For this, we treated cells with 2 mM HU for 24 h, as we had seen the most dramatic differences in the levels of DSBs using this regimen. Using uorescence microscopy, we found a reduced level of the ubiquitylation-resistant RAD51 localized to the cytoplasm, as compared with cells expressing the WT RAD51 protein (Fig. 4a,b; Po0.05 using an unpaired t-test). Consistent with this, a correspondingly increased number of RAD51 nuclear foci were evident in the K58/K64 RAD51-expressing cells (Fig. 4c; Po0.05 using an unpaired t-test, compared with the WT RAD51 cells). Importantly, these experiments were performed without permeabilizing the cell membrane before xing the cells, to preserve the cytoplasmic RAD51 signal. Following depletion of the endogenous RAD51 messenger RNA, the cells were also analysed for the subcellular localization of the transfected RAD51. As shown in Supplementary Fig. 4a, there was a substantial

difference in the percentage of cells expressing RAD51 in the cytoplasm, with an approximately tenfold greater proportion of cytoplasmic RAD51 seen in the cells expressing WT RAD51 compared with those expressing K58/64R RAD51, conrming the data presented in Fig. 4ac. Consistent with these immunouorescence data, we demonstrated that the K58/64R RAD51 was approximately equally distributed between the chromatin and soluble fractions, whereas the WT RAD51 was strongly concentrated in the soluble fraction (Fig. 4d). This localization bias was not affected by depleting the endogenous RAD51 with an siRNA targeting the 30-UTR of RAD51 (Supplementary

Fig. 4b).

RAD51 ubiquitylation does not prevent BRCA2 interaction. The BRCA2 protein has been shown to interact with and stimulate RAD51 loading onto RPA-coated ssDNA2932. Therefore, we tested the proposal that RAD51 ubiquitylation might interfere with its ability to interact with BRCA2. To do this, we analysed the co-immunoprecipitation of RAD51 or K58/64 RAD51 with BRCA2 in cells in which the endogenous RAD51 had been depleted. As shown in Fig. 5, the WT and K58/64R RAD51 proteins were equally effective at co-immunoprecipitating endogenous BRCA2, suggesting that ubiquitylation of RAD51 does not affect the RAD51BRCA2 interaction.

DiscussionThe UvrD family of DNA helicases appears to play a number of roles in the cellular response to both DNA damage and DNA replication stress. Some, but not all, eukaryotes express a specialized UvrD family member, FBH1, which combines a helicase function with the ability to ubiquitylate target proteins. Previous results from analysis of S. pombe, mouse and human cells have indicated that the helicase activity of FBH1 is an important regulator of the function of RAD51. The data presented here indicate that RAD51 is also a substrate for the F-box-mediated E3 ubiquitin ligase action of FBH1.

Analysis of the FBH1-mediated ubiquitylation reaction suggests that RAD51 can be targeted on several lysine residues in vitro, although each protein is rarely modied more than once. The apparent monoubiquitylation of RAD51 generated by FBH1 is different from the polyubiquitylation events more usually seen with other SCF complexes. Among the ve lysine residues being ubiquitylated in vitro by FBH1, some lie within domains of the protein that are critical for function. K58 is adjacent to E59, which is involved in the interaction with the BRC4 peptide of BRCA2 (ref. 33). Although we showed that the WT and K58/64R RAD51 proteins were equally effective at co-immunoprecipitating endogenous BRCA2, there is still a possibility that ubiquitylation of K58 might affect the RAD51BRCA2 interaction under some circumstances. K64 has also been shown to be crucial in binding to both ssDNA and double-stranded DNA34. Similarly, K285 is a part of the ssDNA-binding loop 2 domain35. Ubiquitylation on K64 and K285 might, therefore, affect the RAD51DNA interaction. In contrast, K156 lies within the ATPase core domain35. Ubiquitylation on K156 could possibly affect ATP binding and hydrolysis. The consequences of ubiquitylation on K107 remain unknown, as this residue does not seem to lie within any functional domain. We focused on analysis of two adjacent lysine residues in the non-catalytic N-terminal domain of RAD51, because the mass spectrometry data indicated that these were quantitatively by far the most important. Consistent with this, we found that the double K58/64R mutant was only very poorly ubiquitylated in vitro by the SCFFBH1 complex.

To dene whether ubiquitylation of K58 and K64 of RAD51 plays a role in the regulation of RAD51s function in DNA repair

NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 5

& 2015 Macmillan Publishers Limited. All rights reserved.

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931

2 mM HU 24 h

WT RAD51

% Of cells with

cytoplasmic RAD51 signal

100

100

% Of cells with

>5 RAD51 foci per cell

80

80

60

60

K58/64R RAD51

40

40

20

20

0

0

WT

RAD51

K58/64R

RAD51

WT

RAD51

K58/64R

RAD51

Chromatin fraction

Soluble fraction

WCE

U2OS + hRAD51:

Chromatin Soluble

K58/64R

K58/64R

K58/64R

RAD51 relative to WT

21.61.20.80.4 0

WT

WT

WT

TOPOII

RAD51

GRB2

130 kDa

25 kDa

WT K58/64R

37 kDa

RAD51 relative to WT

1.2

0.8

0.4

0

WT K58/64R

Figure 4 | Ubiquitylation of RAD51 regulates its intracellular localization. (a) Examples of RAD51 staining (green) in WT RAD51- and K58/64R RAD51-expressing cells after treatment with 2 mM HU for 24 h. Nuclei were stained with DAPI (blue). Scale bars, 10 mm (white). (b) The means of the percentage of cells showing cytoplasmic RAD51 staining are shown for three independent experiments. At least 50 cells for each cell line were quantied in each experiment. (c) The means of cells showing more than ve RAD51 nuclear foci are shown for three independent experiments. At least 50 cells for each cell line were quantied in each experiment. (d) WT and K58/64R RAD51-expressing cells were exposed to 2 mM HU for 24 h. Whole-cell extracts (WCE), chromatin-bound proteins and soluble proteins were separated by SDSPAGE and the samples were western blotted with an anti-TOPIIa antibody (a marker for chromatin bound proteins), an anti-RAD51 antibody, or an anti-GRB2 antibody (a marker for cytoplasmic proteins). In the right hand panels, the relative amount of RAD51 WT (black bars; set at 1 in each case) and K58/64R RAD51 (hatched bars) in the chromatin (upper) and soluble (lower) fractions were quantied by using ImageJ software. The means are shown for three independent experiments. Error bars represent s.d.

2 mM HU RAD51 3-UTR siRNA

Input RAD51 IP

Input IgG IP

300 kDa

59 kDa39 kDa WB: RAD51

K58/64R

K58/64R

K58/64R

K58/64R

WT

WT

WT

WT

WB: BRCA2

300 kDa

59 kDa 39 kDa

Figure 5 | RAD51 ubiquitylation does not disrupt the RAD51BRCA2 interaction. WT RAD51- and K58/64R RAD51-expressing cells were treated with an siRNA targeting the 3-UTR of RAD51 for 72 h, followed by a treatment with 2 mM HU for 24 h. Whole-cell extracts of WT RAD51- and K58/64R RAD51-expressing U2OS cells were incubated with anti-RAD51 (left panel) or anti-IgG control (right panel) antibodies. Precipitated proteins were separated by SDSPAGE and the samples were western blotted with anti-BRCA2 and anti-RAD51 antibodies, as indicated.

or DNA replication, we compared the response of cells expressing either ectopic WT RAD51 or K58/64R RAD51 with a prolonged exposure to HU. We found several differences between these two transfected cell populations; most notably, the nuclear accumulation of K58/64R RAD51 was more prominent than it was with WT RAD51 following exposure to HU, and this was accompanied by enhanced HU resistance, a reduced level of HU-induced DSBs and hyperrecombination. These data support the model whereby ubiquitylation of RAD51 by FBH1 does not function to trigger

RAD51 turnover by proteolysis, as is seen with several SCF-mediated ubiquitylation events, but rather serves to regulate the subcellular localization of RAD51. This suggests a potentially new paradigm for how SCF proteins can regulate target protein function. Nevertheless, our analyses would not detect the proteolytic removal of a small fraction of cellular RAD51 that exists, for example, at a very specic nuclear location. A previous study did observe that RAD51 is degraded via ubiquitylation, in a reaction that is regulated by RAD51C36. However, we found equivalent RAD51 protein levels in WT and K58/64R RAD51-expressing cells. On the other hand, it has also been reported that FBH1 is recruited to DNA replication and DNA damage sites by proliferating cell nuclear antigen (PCNA)37. Interestingly, FBH1 can itself be ubiquitylated (by CRL4Cdt2), which leads to FBH1 degradation37. Moreover, ubiquitylation of FBH1 modulates its interaction with RAD51 (ref. 38). Therefore, the relationship between FBH1 and RAD51 is probably controlled by multiple ubiquitylation events.

There are a number of striking parallels between the phenotype of mammalian cells expressing the ubiquitylation-resistant form of RAD51 and those carrying a deletion in the helicase domain of FBH1. Our previous analysis of a mouse ES cell line with an internal deletion in the Fbh1 helicase domain showed that these cells are HU resistant, hyperrecombinogenic and less prone to accumulate DSBs following replication stress23, all phenotypes reported here for the K58/64R RAD51-expressing cells. In the mouse mutant cells, RAD51 nuclear staining was prominent, even without exogenous DNA damage/replication blockade. In the

6 NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

& 2015 Macmillan Publishers Limited. All rights reserved.

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931 ARTICLE

RAD51

Ubiquitin-activating (E1) enzyme

1. Inappropriate loading of RAD51 onto ssDNA risks unscheduled HR

3. FBH1 F-box activity targets RAD51 for ubiquitylation preventingRAD51 reassociation with the DNA

E1

E2

Replication fork

Ub

Ubiquitin-conjugating (E2) enzyme

SKP1/CUL1/FBH1

FBH1 FBH1

2. FBH1 translocates along the DNA and displaces RAD51

Exposed ssDNA

SCF E3 complex

Ubiquitin

SCF E3 complex

Ub

E2

Ub

E1

Ub

Figure 6 | Model for the proposed action of FBH1 at stalled DNA replication forks. Relevant proteins are shown, as indicated in the key. We propose that FBH1 translocates along DNA, where a physical interaction with RAD51 causes the dissociation of RAD51 from the developing nucleolaments. Following this displacement of RAD51, the SCFFBH1 targets RAD51 for ubiquitylation, preventing its re-association with the DNA.

current work, the differences apparent following manipulation of the ubiquitylation status of RAD51 were only seen following replication stress. Nevertheless, the most straightforward explanation for these data is that the helicase and F-box functions of FBH1 operate together to regulate the same protein target or targets (see model in Fig. 6). Our data indicate that one key target in human cells is RAD51, but do not exclude the possibility that other targets for FBH1 exist. However, the fact that we can dominantly change the cellular response to HU simply by expressing a form of the proposed target protein that has altered ubiquitylation argues strongly that RAD51 is an important target for FBH1 during the cellular response to dNTP depletion and replication blockade. As ssDNA is commonly found adjacent to perturbed DNA replication sites, we tested the effect of ssDNA on the ubiquitylation reaction. Although we found that the presence of ssDNA does not alter the efciency of the FBH1-mediated ubiquitylation reaction, it nevertheless might affect the specicity of the reaction in vivo.

Methods

Protein purication. E. coli expressing recombinant human RAD51 protein were lysed and sonicated in lysis buffer (0.1 M Tris-HCl pH 8, 2 mM EDTA, 5% glycerol,0.5 mM dithiothreitol (DTT), 0.2 mg ml 1 phenylmethylsulfonyl uoride and 0.1% Triton X-100). The soluble protein fraction was dialysed against spermidine buffer (20 mM Tris-acetate pH 7.5, 7 mM spermidine-NaOH and 0.1 mM DTT). Precipitates were collected and dissolved in P100 buffer (0.1 M potassium phosphate pH 6.8, 0.1 M KCl, 10% glycerol and 0.5 mM DTT) and were then loaded onto a hydroxyapatite column (Bio-Rad). Bound proteins were eluted with H buffer(0.1 M KCl, 10% glycerol and 0.5 mM DTT, containing a gradient of 0.10.8 M potassium phosphate pH 6.8). Fractions containing RAD51 were pooled and dialysed against R buffer (20 mM Tris-HCI pH 8, 1 mM EDTA, 0.5 mM DTT, 10% glycerol) containing 0.1 M KCl. Lysate was then loaded onto a heparin sepharose column (GE Healthcare) and eluted in R buffer with a linear gradient of 0.10.8 M KCl. Fractions containing RAD51 were again pooled and dialysed against R buffer containing 0.1 M KCl. Eluate was then loaded onto a mono-Q column (GE Healthcare) and eluted in R buffer with a linear gradient of 0.10.8 M KCl. Eluate was concentrated, dialysed against storage buffer (20 mM Tris-acetate pH 8, 0.2 M potassium acetate, 10% glycerol, 1 mM EDTA and 0.5 mM DTT) and stored at

80 C7.S. cerevisiae expressing histidine-tagged human BLM protein were lysed in buffer A (50 mM HEPES-OH pH 7.2, 250 mM KCl, 10% glycerol and EDTA-free protease inhibitor (Roche)). The soluble protein fraction was subjected to nickel chelate afnity chromatography. The bound protein was eluted in buffer A containing 250 mM EDTA with an imidazole gradient of 501,500 mM. Fractions containing BLM were dialysed against buffer A containing 1 mM EDTA, 1 mM 2-mercaptoethanol and 0.1 mM phenylmethylsulfonyl uoride, and stored at

80 C39. Puried FANCD2 was a kind gift from Dr J.-Y. Masson. Puried RPA was a kind gift from Dr Pavel Janscak.

To purify the SCFFBH1 complex, the FBH1 cDNA was obtained from an IMAGE clone library and was sub-cloned into pFastBac HT-A (Life Technologies,

Inc.). The plasmid was then transformed into E. coli DH10Bac and recombinant bacmids were isolated for baculovirus preparation. Recombinant bacmids were transfected into SF21 cells to produce virus stocks. Baculoviruses encoding glutsthopne S-transferase (GST)-tagged SKP1, CUL1 and ROC1 were kindly provided by Dr Pavel Janscak. For SCFFBH1 complex production, SF21 cells were infected with the mixture of four recombinant baculoviruses: His-tagged FBH1, GST-tagged SKP1, and untagged CUL1 and ROC1, and the cells were incubated for 3 days. The infected SF21 cells were harvested and washed twice with ice-cold PBS. Cells were then lysed using lysis buffer (50 mM sodium phosphate buffer (pH7.4), 300 mM NaCl, 1 mM EDTA, 2 mM b-mercaptoethanol, 10% glycerol, 0.1%

Nonidet P-40, Proteinase inhibitor complete (Roche)) for 1 h on ice. The lysate was claried by centrifugation (Beckman, 70Ti, 70,000g, 4 C, 1 h) and the supernatant was subsequently incubated with glutathione sepharose resin (GE healthcare) for 3 h. After the incubation, the resin was transferred to a disposable column (BioRad) and was washed with 20 bed volumes of GST-wash buffer (50 mM sodium phosphate buffer (pH7.4), 300 mM NaCl, 10% glycerol, 2 mM b-mercaptoethanol).

Bound proteins were eluted using GST-elution buffer (50 mM sodium phosphate buffer (pH 7.4), 20 mM glutathione, 300 mM NaCl, 10% glycerol, 2 mM bmercaptoethanol). The eluted fractions were incubated with Ni-NTA agarose (QIAGEN) overnight. The resin was transferred to a disposable column and was washed sequentially with HS wash buffer (50 mM sodium phosphate buffer (pH7.4), 500 mM NaCl, 10% glycerol, 1 mM b-mercaptoethanol, 10 mM imidazole)

and IM wash buffer (50 mM sodium phosphate buffer (pH7.4), 300 mM NaCl, 10% glycerol, 1 mM b-mercaptoethanol, 25 mM imidazole). Bound proteins were eluted with HIS-elution buffer (50 mM sodium phosphate buffer (pH7.4), 300 mM NaCl, 10% glycerol, 1 mM b-mercaptoethanol, 300 mM imidazole). Aliquots were frozen in liquid N2 and stored at 80 C.

In vitro ubiquitylation assays. A complete ubiquitylation reaction (10 ml), containing ubiquitylation buffer (50 mM HEPES-NaOH pH 7.5, 100 mM NaCl, 10 mM MgCl2, 5 mM ATP, 0.1 mM DTT), 100 nM ubiquitin activating enzyme (Boston

Biochem), 500 nM UbcH5a (Boston Biochem), 8 mM untagged or HA-tagged ubiquitin (Boston Biochem), 20 nM puried RAD51 and 5 ng ml 1 SCFFBH1, was incubated at 37 C for the indicated times. The reactions were terminated by incubation with 10 ml stop buffer (100 mM Tris-HCl pH 8, 5 mM EDTA pH 8.0,0.2% SDS, 200 mM NaCl, 200 mg ml 1 proteinase K) at 65 C for 15 min. The reaction products were analysed by SDSPAGE followed by western blotting with antibodies against RAD51 (1:200, Abcam ab1837), BLM (1:1,000, Abcam ab476), FANCD2 (1:200, Santa Cruz sc28194), RPA14 (1:1,000, Tebu-bio GTX70238), RPA34 (1:1,000, Abcam ab2175) or RPA70 (1:1,000, NeoMarkers MS-692-P) using standard methods. Where indicated, 25 mg ml 1 ssDNA was included in the reaction. To test the ability of different E2 enzymes to support the ubiquitylation reaction, 500 nM Cdc34 or UbcH6 was used instead of UbcH5a. Cdc34 was also tested at the same concentration in combination with UbcH5, to assess whether this enhanced the reaction efciency, as has been suggested previously40. Nedd8 (25 mM)- and Nedd8-activating enzyme (100 nM) were tested based on reports that

SCF-mediated polyubiquitylation is activated by conjugation of Nedd8 to human CUL1 (refs 41,42), probably via conformational changes in CUL1 (ref. 43).

Immunoprecipitation of FBH1 and RAD51. Two hundred nanograms of GST (Santa Cruz) or GST-FBH1 was incubated with 4 pmol WT or K58/64R RAD51 in 500 ml binding buffer (10 mM Tris-HCl pH8, 150 mM NaCl, 1 mM EDTA and0.2% TrintonX-100) at 4 C for 15 min. Forty microlitres of Glutathione Sepharose (GE Healthcare) was added and the protein mixture was incubated at 4 C for 1 h.

NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 7

& 2015 Macmillan Publishers Limited. All rights reserved.

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931

The sepharose was collected and washed with the binding buffer ve times. The sepharose was then boiled with the sample buffer (0.4% SDS, 2% glycerol, 12 mM Tris-HCl pH 6.8, 0.1% (w/v) bromophenol blue, 5% (w/v) b-mercaptoethanol) and the released proteins were analysed by using western blotting. Membranes were probed with antibodies against GST (1:200, Santa Cruz sc138) or RAD51 (1:1,000, Santa Cruz sc8349).

Mass spectrometry-based analysis of RAD51 ubiquitylation. Proteins were resolved by SDSPAGE, followed by in-gel digestion with trypsin. Peptide fractions were analysed on a Orbitrap mass spectrometer (Velos, Thermo Scientic) equipped with a nanoow HPLC system (Thermo Scientic) using a data-dependent method, dynamically choosing the ten most abundant precursor ions from the survey scan for higher energy collisional dissociation fragmentation. Survey scans were acquired at a resolution of 30,000 at m/z 400, while the resolution for higher energy collisional dissociation spectra was set to 7,500 at m/z 400 (ref. 44). Raw data les were analysed using MaxQuant software (version 1.2.2.9)45.

Cell culture. Human U2OS cells (obtained from the ATCC) were maintained in DMEM medium supplemented with 10% FCS and 2.4 mM glutamine. Cells were grown at 37 C in a humidied atmosphere containing 5% CO2. Cells were transfected with plasmids expressing WT or mutated RAD51 under the control of cytomegalovirus promoter in vector pcDNA3 (a gift from Dr Fiona Benson) using standard techniques. Where indicated, cells were transfected with control siRNA (50-UCUGUCGUUAGUGUCACCGGUCAUA-30) or siRNA targeting the 30-UTR of the RAD51 gene (50-UCUUCCUGUUGUG ACUGCCAGGAUA-30) for 72 h before HU treatment. To target the coding region of RAD51, the following siRNA was used: 50-GCGACUCGCUGAUGAGUUUTT-30. As a control, an siRNA with the following sequence was used: 50-GCGGCUGUCG UAGAACUUUTT-30.

Pulsed-eld gel electrophoresis. Cells were treated with 2 mM HU for various times. After treatment, 106 cells were embedded into 0.9% agarose gel plugs using a CHEF disposable plug mould (BioRad). The plugs were incubated in lysis buffer (100 mM EDTA, 1% sodium lauryl sarcosine, 0.2% sodium deoxycholate, 1 mg ml 1 proteinase K) for 2 days and run in an 0.9% agarose gel using a

Rotaphor apparatus (Biometra)46. The gel was then stained with ethidium bromide and the DNA was analysed using a Typhoon 9200 scanner (Amersham). Band intensities were quantied using ImageQuant 5.2 software. All experiments were performed at least three times.

Clonogenic survival assays. Cells were incubated in HU or Aphidicolin-containing medium for 24 h. After treatment, cells were washed with PBS and then grown in fresh medium for 810 days. Colonies were xed, stained and counted using Coomassie solution (0.1% Coomassie Blue, 7% acetic acid, 50% methanol). All experiments were performed at least three times.

DR-GFP recombination assay. The recombination level in U2OS cells was measured by transfecting cells using electroporation (Gene Pulser Xcell, Bio-Rad) with the DSB recombination reporter (which generates an intact GFP gene following recombination) and an I-SceI endonuclease expression vector. A red uorescent protein expression vector was used as a control, to dene transfection efciency. Cells were analysed by ow cytometry for green/red uorescence 3 days after transfection28.

Immunouorescence analysis. Cells in DMEM medium were seeded onto glass coverslips at B25% conuency. Twenty-four hours later, the cells were treated with 2 mM HU and were then incubated at 37 C for 24 h. Cells were then xed in 4% para-formaldehyde in PBS for 10 min, washed in PBS and were stored at 4 C. After permeabilization with 0.1% TritonX-100 in PBS, the cells were washed in freshly made blocking buffer (0.15% glycine (w/v), 0.5% BSA (w/v) in PBS). Staining with primary antibody against RAD51 (1:200, Santa Cruz sc8349) was followed by further washes with 0.1% TritonX-100 in PBS and then incubation with secondary antibody conjugated with AF488 (1:800, Invitrogen A21206). The nuclei were counterstained with DAPI (Vector Laboratories) before the coverslips were sealed to glass slides. RAD51 staining patterns were visualized with a confocal laser scanning microscope (Zeiss LSM 710) and images were stored and analysed using Zeiss LSM Image Browser software.

Separation of soluble and chromatin-associated proteins. Cells were treated with 2 mM HU and incubated at 37 C for 24 h. A pellet of B2 106 cells was

washed three times in PBS and then re-suspended in 250 ml freshly made protein buffer A (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 0.1% TritonX-100, protease inhibitor complete (Roche)) for 1 h at 4 C. The sample was centrifuged at 200g for 4 min at 4 C and the supernatant was stored as the cytoplasmic soluble fraction. The pellet was washed three times in 200 ml Protein Buffer A, centrifuged at 180g for 4 min at 4 C before addition of 175 ml of freshly made protein buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, protease inhibitor complete (Roche)). Incubation continued for 1 h at 4 C, followed by centrifugation at 300 g for 4 min at 4 C. The supernatant was stored as

the nuclear soluble fraction. The pellet was washed three times in 175 ml Protein Buffer B, centrifuged at 16,000g for 1 min at 4 C before the supernatant was discarded, and the pellet (chromatin-associated fraction) was resuspended and boiled in 175 ml Laemmli buffer (0.4% SDS, 2% glycerol, 12 mM Tris-HCl pH 6.8).

For western blotting analysis, 10 BFB-2-ME (0.1% (w/v) bromophenol blue, 5%

(w/v) b-mercaptoethanol) was added, the samples were boiled, and the cytoplasmic and nuclear soluble fractions were combined. Membranes were probed with antibodies against RAD51 (1:1,000, Abcam ab1837), TOPOIIa (1:1,000, Santa Cruz sc5347) or GRB2 (1:1,000, BD Transduction lab 610112). Uncropped gel scans can be found in Supplementary Fig. 5.

DNA bre analysis. U2OS cells were pulse-labelled with 50 mM CldU for 20 min. The cells were rinsed with fresh medium and were incubated with 2 mM HU for 24 h. Cells were rinsed with medium again and pulse labelled with 500 mM IdU for 1 h. For untreated cells, the HU incubation was omitted. Labelled cells were harvested and DNA bres were spread on glass slides47. DNA bres were denatured with 2.5 M hydrochloric acid for 90 min and then rinsed with freshly made blocking buffer (0.15% glycine (w/v), 0.5% BSA (w/v) in PBS). CldU and IdU were detected by incubating slides with primary antibodies (1:40, Abcam ab6326 and 1:2, Becton Dickinson 347580, respectively). DNA bres were washed with blocking buffer again, and then incubated with secondary antibodies conjugated with AF568 (1:200, Invitrogen A11077) or AF488 (1:200, Invitrogen A21200). At least 180 replication structures for each analysis were scored using a Nikon Eclipse 80i microscope equipped with ACT-1 software.

Immunoprecipitation of RAD51 and BRCA2. Cells were treated with 2 mM HU and incubated at 37 C for 24 h. Cells were washed three times in cold PBS and then scraped in 1 ml RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1% TrintonX-100, 0.1% sodium deoxycholate, 1 mM EDTA, 5 mM b-glycerophosphate,1 mM sodium orthovanadate and 5 mM sodium uoride, protease inhibitor complete (Roche)). Cells were lysed in RIPA buffer at 4 C for 30 min. The lysate was sonicated briey and then incubated with RAD51 antibody (1:40, Santa Cruz sc8349) or rabbit IgG antibody (1:80, Santa Cruz sc2027) at 4 C for 1 h. Twenty-ve microlitres of protein G Sepharose (Invitrogen) was added to the lysate and incubated at 4 C for 1 h. The sepharose was collected and washed with the RIPA buffer three times. The sepharose was then boiled with the sample buffer (0.4% SDS, 2% glycerol, 12 mM Tris-HCl pH 6.8, 0.1% (w/v) bromophenol blue, 5% (w/v) b-mercaptoethanol) and analysed by using western blotting. Membranes were probed with antibodies against BRCA2 (1:1,000, Abcam ab123491) or RAD51 (1:1,000, Santa Cruz sc8349).

References

1. Petermann, E. & Helleday, T. Pathways of mammalian replication fork restart. Nat. Rev. Mol. Cell. Biol. 11, 683687 (2010).

2. Hanada, K. et al. The structure-specic endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks. Nat. Struct. Mol. Biol. 14, 10961104 (2007).

3. Petermann, E., Orta, M. L., Issaeva, N., Schultz, N. & Helleday, T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 37, 492502 (2010).

4. Robu, M. E., Inman, R. B. & Cox, M. M. RecA protein promotes the regression of stalled replication forks in vitro. Proc. Natl Acad. Sci. USA 98, 82118218 (2001).

5. Hashimoto, Y., Ray Chaudhuri, A., Lopes, M. & Costanzo, V. Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis. Nat. Struct. Mol. Biol. 17, 13051311 (2010).

6. Schlacher, K. et al. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145, 529542 (2011).

7. Benson, F. E., Stasiak, A. & West, S. C. Purication and characterization of the human Rad51 protein, an analogue of E. coli RecA. EMBO J. 13, 57645771 (1994).

8. Hashimoto, Y., Puddu, F. & Costanzo, V. RAD51- and MRE11-dependent reassembly of uncoupled CMG helicase complex at collapsed replication forks. Nat. Struct. Mol. Biol. 19, 1724 (2011).

9. Luo, G. et al. Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat. Genet. 26, 424429 (2000).

10. Bugreev, D. V., Yu, X., Egelman, E. H. & Mazin, A. V. Novel pro- and anti-recombination activities of the Blooms syndrome helicase. Genes Dev. 21, 30853094 (2007).

11. Hu, Y. et al. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic laments. Genes Dev. 21, 30733084 (2007).

12. Veaute, X. et al. The Srs2 helicase prevents recombination by disrupting Rad51 nucleoprotein laments. Nature 423, 309312 (2003).

13. Krejci, L. et al. DNA helicase Srs2 disrupts the Rad51 presynaptic lament. Nature 423, 305309 (2003).

8 NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

& 2015 Macmillan Publishers Limited. All rights reserved.

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6931 ARTICLE

14. Moldovan, G. L. et al. Inhibition of homologous recombination by the PCNA-interacting protein PARI. Mol. Cell 45, 7586 (2011).

15. Fugger, K. et al. Human Fbh1 helicase contributes to genome maintenance via pro- and anti-recombinase activities. J. Cell Biol. 186, 655663 (2009).

16. Chiolo, I. et al. The human F-Box DNA helicase FBH1 faces Saccharomyces cerevisiae Srs2 and postreplication repair pathway roles. Mol. Cell. Biol. 27, 74397450 (2007).

17. Cardozo, T. & Pagano, M. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell. Biol. 5, 739751 (2004).

18. Osman, F., Dixon, J., Barr, A. R. & Whitby, M. C. The F-Box DNA helicase Fbh1 prevents Rhp51-dependent recombination without mediator proteins. Mol. Cell. Biol. 25, 80848096 (2005).

19. Sakaguchi, C., Morishita, T., Shinagawa, H. & Hishida, T. Essential and distinct roles of the F-box and helicase domains of Fbh1 in DNA damage repair. BMC Mol. Biol. 9, 27 (2008).

20. Morishita, T. et al. Role of the Schizosaccharomyces pombe F-Box DNA helicase in processing recombination intermediates. Mol. Cell. Biol. 25, 80748083 (2005).

21. Lorenz, A., Osman, F., Folkyte, V., Sofueva, S. & Whitby, M. C. Fbh1 limits Rad51-dependent recombination at blocked replication forks. Mol. Cell. Biol. 29, 47424756 (2009).

22. Simandlova, J. et al. FBH1 helicase disrupts RAD51 laments in vitro and modulates homologous recombination in mammalian cells. J. Biol. Chem. 288, 3416834180 (2013).

23. Fugger, K. et al. FBH1 co-operates with MUS81 in inducing DNA double-strand breaks and cell death following replication stress. Nat. Commun. 4, 1423 (2013).

24. Jeong, Y. T., Cermak, L., Guijarro, M. V., Hernando, E. & Pagano, M. FBH1 protects melanocytes from transformation and is deregulated in melanomas. Cell Cycle 12, 11281132 (2013).

25. Jeong, Y. T. et al. FBH1 promotes DNA double-strand breakage and apoptosis in response to DNA replication stress. J. Cell Biol. 200, 141149 (2013).

26. Wagner, S. A. et al. A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 10, M111 013284 (2011).

27. Raderschall, E. et al. Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis. J. Cell. Sci. 115, 153164 (2002).

28. Nakanishi, K., Cavallo, F., Brunet, E. & Jasin, M. Homologous recombination assay for interstrand cross-link repair. Methods Mol. Biol. 745, 283291 (2011).

29. Wong, A. K., Pero, R., Ormonde, P. A., Tavtigian, S. V. & Bartel, P. L. RAD51 interacts with the evolutionarily conserved BRC motifs in the humanbreast cancer susceptibility gene brca2. J. Biol. Chem. 272, 3194131944 (1997).

30. Jensen, R. B., Carreira, A. & Kowalczykowski, S. C. Puried human BRCA2 stimulates RAD51-mediated recombination. Nature 467, 678683 (2010).

31. Liu, J., Doty, T., Gibson, B. & Heyer, W. D. Human BRCA2 protein promotes RAD51 lament formation on RPA-covered single-stranded DNA. Nat. Struct. Mol. Biol. 17, 12601262 (2010).

32. Thorslund, T. et al. The breast cancer tumor suppressor BRCA2 promotes the specic targeting of RAD51 to single-stranded DNA. Nat. Struct. Mol. Biol. 17, 12631265 (2010).

33. Subramanyam, S., Jones, W. T., Spies, M. & Spies, M. A. Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction. Nucleic Acids Res. 41, 90209032 (2013).

34. Aihara, H., Ito, Y., Kurumizaka, H., Yokoyama, S. & Shibata, T. The N-terminal domain of the human Rad51 protein binds DNA: structure and a DNA binding surface as revealed by NMR. J. Mol. Biol. 290, 495504 (1999).

35. Prasad, T. K., Yeykal, C. C. & Greene, E. C. Visualizing the assembly of human Rad51 laments on double-stranded DNA. J. Mol. Biol. 363, 713728 (2006).

36. Bennett, B. T. & Knight, K. L. Cellular localization of human Rad51C and regulation of ubiquitin-mediated proteolysis of Rad51. J. Cell. Biochem. 96, 10951109 (2005).

37. Bacquin, A. et al. The helicase FBH1 is tightly regulated by PCNA via CRL4(Cdt2)-mediated proteolysis in human cells. Nucleic Acids Res. 41, 65016513 (2013).

38. Masuda-Ozawa, T., Hoang, T., Seo, Y. S., Chen, L. F. & Spies, M. Single-molecule sorting reveals how ubiquitylation affects substrate recognition and activities of FBH1 helicase. Nucleic Acids Res. 41, 35763587 (2013).

39. Karow, J. K., Newman, R. H., Freemont, P. S. & Hickson, I. D. Oligomeric ring structure of the Blooms syndrome helicase. Curr. Biol. 9, 597600 (1999).

40. Fong, P. C. et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 361, 123134 (2009).

41. Pan, Z. Q., Kentsis, A., Dias, D. C., Yamoah, K. & Wu, K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23, 19851997 (2004).

42. Saha, A. & Deshaies, R. J. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol. Cell 32, 2131 (2008).

43. Duda, D. M. et al. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134, 9951006 (2008).

44. Michalski, A. et al. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics 10, M111 011015 (2011).

45. Cox, J. & Mann, M. MaxQuant enables high peptide identication rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantication. Nat. Biotechnol. 26, 13671372 (2008).

46. Hanada, K. et al. The structure-specic endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 25, 49214932 (2006).

47. Jackson, D. A. & Pombo, A. Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efcient activation and propagation of S phase in human cells. J. Cell Biol. 140, 12851295 (1998).

48. Flygare, J., Armstrong, R. C., Wennborg, A., Orsan, S. & Hellgren, D. Proteolytic cleavage of HsRad51 during apoptosis. FEBS Lett. 427, 247251 (1998).

Acknowledgements

We thank members of the Hickson laboratory for useful discussions, Drs Y. Liu and

H.W. Mankouri for critical reading of the manuscript, and The Nordea Foundation,

Cancer Research UK, The Association for International Cancer Research, The Danish

Medical Research Council, The European Research Council and The Danish Cancer

Society for nancial support.

Author contributions

W.K.C., M.J.P., P.B. and K.H. designed and performed experiments, and analysed data.

C.C. and I.D.H. designed experiments and analysed data. W.K.C. and I.D.H. wrote the

manuscript.

Additional information

Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications

Web End =http://www.nature.com/

http://www.nature.com/naturecommunications

Web End =naturecommunications

Competing nancial interests: The authors declare no competing nancial interests.

Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions/

Web End =http://npg.nature.com/

http://npg.nature.com/reprintsandpermissions/

Web End =reprintsandpermissions/

How to cite this article: Chu, W. K. et al. FBH1 inuences DNA replication fork stability

and homologous recombination through ubiquitylation of RAD51. Nat. Commun. 6:5931

doi: 10.1038/ncomms6931 (2015).

NATURE COMMUNICATIONS | 6:5931 | DOI: 10.1038/ncomms6931 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 9

& 2015 Macmillan Publishers Limited. All rights reserved.